Patient ‐derived organoid models help define personalized management of gastrointestinal cancer

ConclusionHigh‐throughput drug screening on organoids, combined with next‐generation sequencing, proteomic analysis and other state‐of‐the‐art molecular diagnostic methods, can shape cancer treatment to become more effective with fewer side‐effects.

Source: British Journal of Surgery - January 17, 2018 Category: Surgery Authors: M. R. Aberle, R. A. Burkhart, H. Tiriac, S. W. M. Olde Damink, C. H. C. Dejong, D. A. Tuveson, R. M. van Dam Tags: Review Source Type: research